Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that on May 22, 2025,...
-
NurExone Biologic Inc. announces formation of a U.S.-based subsidiary, Exo-Top Inc. for fully characterized GMP Exosome production.
-
NurExone Biologic Secures Master Cell Bank - a Key Milestone for Therapeutic Exosome Production
-
Austin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Mesenchymal Stem Cells (MSC) Market was valued at USD 3.2 Billion in 2023 and is projected to reach USD 9.72...
-
Selbyville, Delaware, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Spine Biologics Market size is expected to be worth USD 3.4 billion by 2032. The increasing prevalence of spine deformities is the major...
-
BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for...
-
New York, June 27, 2022 (GLOBE NEWSWIRE) -- The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the...
-
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
-
LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) -- The Global Mesenchymal Stem Cells Market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and reach the market value of over US$ 2,600.5...
-
Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 and to reach...